Search - tctmd.com

Displaying 1 - 19 of 19

Sort: Relevancy | Date

News Daily News

Asundexian’s Lack of Efficacy Sinks OCEANIC-AF

L.A. McKeown

November 20, 2023

News Daily News

FDA Approves Paradise Renal Denervation System: What Comes Next?

Todd Neale

November 08, 2023

Presentation TCT 2023

Leaflet Thrombosis and HALT: The Achilles Heel of TTVR?

Presenter: Rahul Sharma

October 26, 2023

Presentation TCT 2023

TCT 732: Bridging Morphology and Flow: Exploring Their interplay in HALT Progression fFllowing TAVR Through CFD Analysis

Presenter: Thangam Natarajan

October 24, 2023

Presentation TCT 2023

TCT 588: Association of Prosthesis Deformation of Balloon-Expandable Transcatheter Aortic Valves With Subclinical Leaflet Thrombosis

Presenter: Shubhadarshini Pawar

October 24, 2023

Presentation TCT 2023

TCT 492: A Data-Driven Bayesian Model To Predict Leaflet Thrombosis After Bioprosthetic Aortic Valve Replacement

Presenter: Yousef Darestani

October 24, 2023

Presentation TCT 2023

TCT 258: Personalized, CT-guided Antithrombotic Therapy Versus Lifelong Single Antiplatelet Therapy to Reduce Thromboembolic and Bleeding Events in Non-atrial Patients After Transcatheter Aortic Valve Implantation

Presenter: Daniel Overduin

October 24, 2023

News Daily News

TCTMD’s Top 10 Most Popular Stories for September 2023

Shelley Wood

October 03, 2023

News Daily News

‘Overwhelming Reduction’ in Bleeding With Abelacimab vs Rivaroxaban in AF

L.A. McKeown

September 18, 2023

Presentation SCCT 2023

HALT – from Diagnosis to Prognosis

Presenter: Omar Khalique

July 28, 2023

News Daily News

Obicetrapib Effective When Added to Statins and Ezetimibe: ROSE2

Michael O'Riordan

June 14, 2023

Presentation TVT 2023

The Case for ‘Default OAC’ in Valve-in-Valve TAVR – Pros and Cons

Presenter: Isaac George

June 08, 2023

Presentation TVT 2023

Case Resolution: A Patient With Recent TAVR, Receiving SAPT, and at 1 Month Has Elevated Gradient on Echo, and CT Shows HALT – Now What

Presenter: Sachin Goel

June 08, 2023

Presentation TVT 2023

SPOTLIGHT LECTURE: Show Me the Data! Is HALT After TAVR Associated With Clinical Events or Accelerated SVD?

Presenter: Raj Makkar

June 08, 2023

Presentation TVT 2023

Prevention of and Antithrombotic Management for HALT and THV Thrombosis

Presenter: Tarun Chakravarty

June 08, 2023

Presentation TVT 2023

Diagnosis, and Imaging Findings in HALT and THV Thrombosis (Workup of Elevated Gradients)

Presenter: Joao Cavalcante

June 08, 2023

Presentation TVT 2023

Case Presentation: A Patient With Recent TAVR, Receiving SAPT, and at 1 Month Has Elevated Gradient on Echo, and CT Shows HALT – Now What?

Presenter: Sachin Goel

June 08, 2023

News Daily News

Andexanet Alfa, Reversal Agent for Factor Xa Inhibitors, Boosts Hemostasis

Todd Neale

June 05, 2023

News Features

Some Rays of Hope for ‘Sorry State’ of Transplant Rejection

Shelley Wood

May 08, 2023

Advertisement

Asundexian’s Lack of Efficacy Sinks OCEANIC-AF

FDA Approves Paradise Renal Denervation System: What Comes Next?

Leaflet Thrombosis and HALT: The Achilles Heel of TTVR?

TCT 732: Bridging Morphology and Flow: Exploring Their interplay in HALT Progression fFllowing TAVR Through CFD Analysis

TCT 588: Association of Prosthesis Deformation of Balloon-Expandable Transcatheter Aortic Valves With Subclinical Leaflet Thrombosis

TCT 492: A Data-Driven Bayesian Model To Predict Leaflet Thrombosis After Bioprosthetic Aortic Valve Replacement

TCT 258: Personalized, CT-guided Antithrombotic Therapy Versus Lifelong Single Antiplatelet Therapy to Reduce Thromboembolic and Bleeding Events in Non-atrial Patients After Transcatheter Aortic Valve Implantation

TCTMD’s Top 10 Most Popular Stories for September 2023

‘Overwhelming Reduction’ in Bleeding With Abelacimab vs Rivaroxaban in AF

HALT – from Diagnosis to Prognosis

Obicetrapib Effective When Added to Statins and Ezetimibe: ROSE2

The Case for ‘Default OAC’ in Valve-in-Valve TAVR – Pros and Cons

Case Resolution: A Patient With Recent TAVR, Receiving SAPT, and at 1 Month Has Elevated Gradient on Echo, and CT Shows HALT – Now What

SPOTLIGHT LECTURE: Show Me the Data! Is HALT After TAVR Associated With Clinical Events or Accelerated SVD?

Prevention of and Antithrombotic Management for HALT and THV Thrombosis

Diagnosis, and Imaging Findings in HALT and THV Thrombosis (Workup of Elevated Gradients)

Case Presentation: A Patient With Recent TAVR, Receiving SAPT, and at 1 Month Has Elevated Gradient on Echo, and CT Shows HALT – Now What?

Andexanet Alfa, Reversal Agent for Factor Xa Inhibitors, Boosts Hemostasis

Some Rays of Hope for ‘Sorry State’ of Transplant Rejection

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content